Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
3
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
ipo
messenger rna
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vc
wisconsin blog main
wisconsin top stories
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amicus therapeutics
approval
apremilast
azacitidine
What
new
3
×
therapeutics
3
×
ipo
million
aims
allogene
approach
based
bio
biotech
biotechs
called
cancer
club
companies
continued
crispr
crop
debuts
developing
diversity
drugs
epigenetic
epigenetics
exceeded
field
firms
flagship’s
group
haul
hot
immunotherapy
investors
joined
juno
latest
life
medicines
met
momentum
Language
unset
Current search:
therapeutics
×
new
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
